The Prostate Health Index (phi) test assesses a patient’s probability of having detectable prostate cancer when total prostate specific antigen (PSA) concentrations are between 4-10 ng/mL. Alicia Algeciras-Schimnich, Ph.D., Chair of Mayo Clinic's Division of Clinical Biochemistry provides an overview of this test.
Ещё видео!